# Efficacy and Safety of Panlongqi Tablet in Patients With Knee Osteoarthritis

> **NCT03327012** · PHASE3 · UNKNOWN · sponsor: **Guang'anmen Hospital of China Academy of Chinese Medical Sciences** · enrollment: 300 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** Treatment of Panlongqi Tablet
- **DRUG:** Treatment of Panlongqi placebo

## Key facts

- **NCT ID:** NCT03327012
- **Lead sponsor:** Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-01
- **Primary completion:** 2019-03-28
- **Final completion:** 2019-07-28
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2017-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03327012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03327012, "Efficacy and Safety of Panlongqi Tablet in Patients With Knee Osteoarthritis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03327012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*